Answers are grounded in this paper and cite their sources.
We compared immune responses to intranasal and intramuscular DNA vaccinations against human immunodeficiency virus type 1 with monophosphoryl lipid A (MPL) used as an adjuvant. Both routes of vaccination resulted in similar levels of cell-mediated immunity, but the intestinal secretory immunoglobulin A response was higher following intranasal immunization than after intramuscular immunization. MPL demonstrated its adjuvanticity in vaccination by both routes.
No takes yet. Share an insight, caveat, or question.
Sasaki et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: